Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serum levels of Asprosin in patients diagnosed with coronary artery disease (CAD): a case-control study
Nariman Moradi, Fatima Zahraa Fouani, Akram Vatannejad, et al.
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Asprosin inhibits macrophage lipid accumulation and reduces atherosclerotic burden by up-regulating ABCA1 and ABCG1 expression via the p38/Elk-1 pathway
Jin Zou, Can Xu, Zhen-Wang Zhao, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 33
Adipokines in atherosclerosis: unraveling complex roles
Jiaying Luo, Zhiwei He, Qingwen Li, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 15
Predictive Value of Selected Plasma Biomarkers in the Assessment of the Occurrence and Severity of Coronary Artery Disease
Małgorzata Wojciechowska, Michał Nizio, Katarzyna Wróbel, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 537-537
Open Access
Low Serum Asprosin Levels in Fi-Bromyalgia Syndrome: Insights from a Cross-Sectional Study
Muhammed Fuad Uslu, Emine Yıldırım Uslu, Sevler Yıldız, et al.
Medicina (2025) Vol. 61, Iss. 3, pp. 410-410
Open Access
Elevated serum asprosin and ANGPTL8 gene expression as novel biomarkers for the diagnosis and prognosis of acute coronary syndrome
Zainulabdin Abdulnabi Abdulah Albreej, Gholamreza Dehghan, Alireza Nourazarian, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
Asprosin, a C-Terminal Cleavage Product of Fibrillin 1 Encoded by the <b><i>FBN1</i></b> Gene, in Health and Disease
Mehmet Akif Ovalı, İbrahim Bozgeyik
Molecular Syndromology (2022) Vol. 13, Iss. 3, pp. 175-183
Open Access | Times Cited: 16
Correlation of asprosin and Nrg-4 with type 2 diabetes Mellitus Complicated with Coronary Heart Disease and the Diagnostic Value
Min Zhong, Xue Tian, Qitian Sun, et al.
BMC Endocrine Disorders (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Exercise-induced effects on asprosin and indices of atherogenicity and insulin resistance in males with metabolic syndrome: a randomized controlled trial
Agnieszka Suder, Karol Makiel, Aneta Targosz, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Asprosin: its function as a novel endocrine factor in metabolic-related diseases
Yang Zhang, Ping Yang, Xinliang Zhang, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 8, pp. 1839-1850
Closed Access | Times Cited: 3
Asprosin aggravates vascular endothelial dysfunction via disturbing mitochondrial dynamics in obesity models
Yanli Lu, Wanwan Yuan, Xiaowei Xiong, et al.
Obesity (2023) Vol. 31, Iss. 3, pp. 732-743
Closed Access | Times Cited: 7
Circulating Asprosin Concentrations in Patients with Obesity and Carbohydrate Disturbances
Iveta Nedeva, Yavor Assyov, Vera Karamfilova, et al.
Hormone and Metabolic Research (2023) Vol. 55, Iss. 04, pp. 284-289
Closed Access | Times Cited: 7
Fibrillin-1 and asprosin, novel players in metabolic syndrome
Kim Summers, Stephen J. Bush, Margaret R. Davis, et al.
Molecular Genetics and Metabolism (2022) Vol. 138, Iss. 1, pp. 106979-106979
Closed Access | Times Cited: 11
Lack of correlation between asprosin serum levels and hyperphagic behavior in subjects with prader-Willi Syndrome
Maria Felicia Faienza, Mariangela Chiarito, Alessia Aureli, et al.
Journal of Endocrinological Investigation (2024)
Closed Access | Times Cited: 2
Can the new adipokine asprosin be a metabolic troublemaker for cardiovascular diseases? A state-of-the-art review
Zhengbin Zhang, Liwen Zhu, Ziqian Wang, et al.
Progress in Lipid Research (2023) Vol. 91, pp. 101240-101240
Closed Access | Times Cited: 6
Effects of exercise and dietary interventions on asprosin, leptin, and lipid metabolism in males with abdominal obesity, a randomized controlled trial
Agnieszka Suder, Karol Makiel, Aneta Targosz, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Associations of Abdominal Visceral Fat Content and Plasma Adiponectin Level With Intracranial Atherosclerotic Stenosis: A Cross-Sectional Study
Fei-Hong Wang, Long-Yan Meng, Tongya Yu, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 6
The role of serum asprosin levels in predicting the severity of coronary artery disease in patients with diabetes mellitus
Ismail Yıgıtdol, Erdinç Gülümsek, Derya Demirtaş, et al.
Irish Journal of Medical Science (1971 -) (2024) Vol. 193, Iss. 3, pp. 1239-1247
Closed Access
The correlation between serum asprosin and left ventricular diastolic dysfunction in elderly patients with type 2 diabetes mellitus in the community
Liang Dong, Guoliang Shi, Mingang Xu, et al.
Journal of Diabetes Investigation (2024) Vol. 15, Iss. 5, pp. 608-613
Open Access
Serum myeloperoxidase, paraoxonase, and plasma asprosin concentrations in patients with acute myocardial infarction
Handan Çiftçi, Hüseyin Fatih Gül, Levent Şahin, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e29465-e29465
Open Access
Relationship between atherogenic index of plasma, asprosin, and metrnl levels in hemodialysis patients
Meltem Yardım
International journal of medical biochemistry/International journal of medical biochemistry : (2024), pp. 60-66
Open Access
Effects of atypical antipsychotics on serum asprosin level and other metabolic parameters in patients with schizophrenia
Kiumarth Amini, Mohammad‐Javad Motallebi, Kimia Bakhtiari, et al.
Human Psychopharmacology Clinical and Experimental (2024) Vol. 39, Iss. 5
Closed Access
Hydroxytyrosol has a cardioprotective effect through dardarin and asprosin
Nevin Kocaman, Elif Onat
Archives of Medical Science - Civilization Diseases (2024) Vol. 9, Iss. 1, pp. 1-6
Open Access
The Effect of High Intensity Interval Training on Asprosin and Oxidative Stress in The Heart Tissue of Type 2 Diabetic Male Rats
M. Tabatabaei, Rohollah Ranjbar, Farhad Daryanoosh, et al.
(2023)
Closed Access | Times Cited: 1
Subfatin, Asprosin, Alamandine and Maresin-1 Inflammation Molecules in Cardiopulmonary Bypass
Onur Hanbeyoğlu, Suna Aydın
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 3469-3477
Open Access | Times Cited: 1
Serum asprosin levels are increased in patients with periodontitis and ST‐segment elevation myocardial infarction and correlated with periodontal parameters: A case–control study
Sema Nur Sevinç Gül, Oğuzhan Birdal, Esra Laloğlu
Journal of Periodontal Research (2023) Vol. 59, Iss. 2, pp. 259-266
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top